Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2020-02-21 2020-01-29
Drug Identification Number 00263818 00263818
Brand name COTAZYM COTAZYM
Common or Proper name PANCRELIPASE CAPSULES PANCRELIPASE CAPSULES
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients AMYLASE PROTEASE LIPASE AMYLASE PROTEASE LIPASE
Strength(s) 40000UNIT 35000UNIT 10000UNIT 40000UNIT 35000UNIT 10000UNIT
Dosage form(s) CAPSULE (IMMEDIATE RELEASE) CAPSULE (IMMEDIATE RELEASE)
Route of administration ORAL ORAL
Packaging size 100CAP 100CAP
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-01-31 2020-01-31
Actual start date 2020-01-29 2020-01-29
Estimated end date 2020-02-21 2020-02-21
Actual end date 2020-02-20
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments